Borosil Scientific achieved a significant financial turnaround in the June 2026 quarter, reporting a consolidated net profit of ₹4.37 crore compared to a net loss of ₹4.16 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this marks a complete reversal of the company's financial performance from the same period last year.
The company's sales revenue increased by 11.22% to ₹106.75 crore in Q1 FY27, up from ₹95.98 crore recorded in the June 2025 quarter. As reported by Business Standard, this revenue growth demonstrates the company's improved operational performance and market demand during the quarter. The latest earnings report confirms this revenue figure as ₹1,067.52 million compared to ₹959.76 million a year ago.
The company's operating profit margin (OPM) improved to 7.92% in Q1 FY27, compared to 5.07% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion indicates enhanced operational efficiency and cost management during the quarter. The improved profitability was further reflected in the company's basic earnings per share from continuing operations of ₹0.49 compared to a basic loss per share of ₹0.47 a year ago.
Profit Before Depreciation and Tax (PBDT) surged by 47% to ₹10.87 crore in Q1 FY27, up from ₹7.40 crore in the June 2025 quarter. As reported by Business Standard, Profit Before Tax (PBT) increased by 136% to ₹5.98 crore compared to ₹2.53 crore in the previous year's corresponding quarter, reflecting the company's improved financial health. The latest earnings report confirms this strong bottom-line performance with net income of ₹43.71 million compared to the previous year's net loss.
